Pages

▼
Tuesday, October 15, 2024

If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?

›
A new survey of plan sponsors sheds light on their satisfaction with transparency at large and small pharmacy benefit managers (PBMs). As y...
Friday, October 11, 2024

As MFP Approaches, Transparency Is More Important Than Ever

›
Today’s guest post comes from Angie Franks, Chief Executive Officer of Kalderos. Angie discusses how the Maximum Fair Price provision of ...
Wednesday, October 09, 2024

Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond

›
As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolu...
Tuesday, October 08, 2024

NOW AVAILABLE: 2024–25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

›
I am pleased to announce Drug Channels Institute's new 2024–25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors ...
Monday, October 07, 2024

Informa Connect’s PBM Contracting Summit

›
Informa Connect’s PBM Contracting Summit December 10-11, 2024 | Chicago, IL Drug Channels readers save 10% with code 24DRCH10 * Expert...
Friday, October 04, 2024

Innovative Models for Improving Access and Visibility for Specialty-Lite and Retail Therapies

›
Today’s guest post comes from Timothy Nielsen, Vice President of Customer Success at AssistRx. Timothy discusses the affordability and pa...
Thursday, October 03, 2024

Another IRA Surprise: Part B Coinsurance Inflation Adjustments Are Increasing Patient Costs (rerun)

›
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholes...
Wednesday, October 02, 2024

Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis (rerun)

›
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholes...
Tuesday, October 01, 2024

Why PBMs and Payers Are Embracing Insulin Biosimilars with Higher Prices—And What That Means for Humira (rerun with an FTC update)

›
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholes...
Monday, September 30, 2024

Informa Connect's Copay, Reimbursement and Access Congress

›
Informa Connect's Copay, Reimbursement and Access Congress November 18-20, 2024 | Hilton Penn’s Landing in Philadelphia, PA Drug Chan...
Friday, September 27, 2024

The Pivotal Role of Technology in Delivering Effective Patient Services

›
Today’s guest post comes from George Moore, Chief Information Technology Officer at CareMetx. As George explains using novel survey data, ...
Wednesday, September 25, 2024

NEW: The Drug Channels 2025 Video Webinar Series

›
Drug Channel Institute is pleased to announce The Drug Channels 2025 Video Webinar Series . Join Dr. Adam J. Fein for three live video webin...